Daratumumab is very efficacious in multiple myeloma. Few reports are present about efficacy in extramedullary myeloma. We report here daratumumab efficacy in extramedullary ocular myeloma in a young 46-year-old man diagnosed 3 years earlier and relapse refractory to five previous lines of therapy. © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Gozzetti, A., Cerase, A., Bocchia, M. (2020). Daratumumab efficacy in extramedullary orbital myeloma. CLINICAL CASE REPORTS, 8(12), 3652-3653 [10.1002/ccr3.3458].

Daratumumab efficacy in extramedullary orbital myeloma

Gozzetti, Alessandro
;
Cerase, Alfonso;Bocchia, Monica
2020-01-01

Abstract

Daratumumab is very efficacious in multiple myeloma. Few reports are present about efficacy in extramedullary myeloma. We report here daratumumab efficacy in extramedullary ocular myeloma in a young 46-year-old man diagnosed 3 years earlier and relapse refractory to five previous lines of therapy. © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
2020
Gozzetti, A., Cerase, A., Bocchia, M. (2020). Daratumumab efficacy in extramedullary orbital myeloma. CLINICAL CASE REPORTS, 8(12), 3652-3653 [10.1002/ccr3.3458].
File in questo prodotto:
File Dimensione Formato  
ccr3.3458.pdf

accesso aperto

Descrizione: Articolo
Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 297.61 kB
Formato Adobe PDF
297.61 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1118443